2016
DOI: 10.1055/s-0036-1571340
|View full text |Cite
|
Sign up to set email alerts
|

Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders

Abstract: Congenital fibrinogen disorders are classified into two types of plasma fibrinogen defects: type I (quantitative fibrinogen deficiencies), that is, hypofibrinogenemia or afibrinogenemia, in which there are low or absent plasma fibrinogen antigen levels, respectively, and type II (qualitative fibrinogen deficiencies), that is, dysfibrinogenemia or hypodysfibrinogenemia, in which there are normal or reduced antigen levels associated with disproportionately low functional activity. These disorders are caused by m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
39
0
4

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(43 citation statements)
references
References 56 publications
0
39
0
4
Order By: Relevance
“…Fibrinogen is synthesized in the liver. Decrease in fibrinogen level in this study after amoxicillin overdose could be associated with the hepatotoxic effect of amoxicillin that can cause a decrease in the physiological function of the liver, which includes the production of fibrinogen [20][21][22][23][24][25][26][27].…”
Section: Discussionmentioning
confidence: 76%
See 1 more Smart Citation
“…Fibrinogen is synthesized in the liver. Decrease in fibrinogen level in this study after amoxicillin overdose could be associated with the hepatotoxic effect of amoxicillin that can cause a decrease in the physiological function of the liver, which includes the production of fibrinogen [20][21][22][23][24][25][26][27].…”
Section: Discussionmentioning
confidence: 76%
“…Fibrinogen is a plasma glycoprotein and an acute phase protein produced by liver cells and the most abundant clotting factor. Plasma fibrinogen is used to determine inherited deficiency, unexplained or prolonged bleeding, and risk of cardiovascular and heart disease [20][21][22][23][24][25][26][27]. Increased fibrinogen concentration can be due to chronic inflammation [20][21][22][23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%
“…[ 4 ] Fibrinogen is a plasma glycoprotein composed of 2964 amino acids, forming a symmetrical hexameric structure (Aα, Bβ, γ) 2 , [ 5 ] which is encoded by 3 fibrinogen genes: FGA, FGB, and FGG; thus, the heterozygous missense mutations existing in most patients occur in 1 of the 3 genes, [ 6 ] and these mutation sites are mainly located on the exon 2 of FGA and exon 8 of FGG. Research suggests CD is responsible for thromboembolic phenomena, bleeding, or both of them, while more than a few patients are asymptomatic, [ 7 ] but the risk of bleeding or thrombosis is higher than that of normal people; moreover, CD patients may suffer from obstetric complications, such as placental abruption, spontaneous abortion, and so on. In this paper, the phenotypic and genotypic analysis of a family with CD was conducted to preliminarily explore the pathogenesis of CD in the family that we discovered.…”
Section: Introductionmentioning
confidence: 99%
“…Inherited fibrinogen disorders can be quantitative (Type I; absence or decreased level of circulating fibrinogen, afibrinogenemia and hypofibrinogenemia, respectively) or qualitative (Type 2; normal or decreased antigenic levels and low fibrinogen activity, dysfibrinogenemia and hypodysfibrinogenemia, respectively) [ 2 , 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Dysfibrinogenemia is caused by structural abnormalities that can be inherited (congenital) or acquired [ 5 ]. Inherited dysfibrinogenemia is caused by mutations in the coding region of the fibrinogen Aα, Bβ or γ genes and the majority of cases result from heterozygous missense mutations [ 4 ]. The prevalence of inherited dysfibrinogenemia in the general population is unknown [ 5 ].…”
Section: Introductionmentioning
confidence: 99%